期刊文献+

初发急性非淋巴细胞白血病SSBP2 mRNA表达研究

The expression of SSBP2 mRNA in primary acute non-lymphocytic leukemia
暂未订购
导出
摘要 目的:探讨SSBP2 mRNA在初发急性非淋巴细胞白血病中的表达。方法:利用半定量RT-PCR检测64例初发急性非淋巴细胞白血病患者及20例正常对照SSBP2 mRNA表达,以β-actin作为内参照。结果:64例初发ANLL患者及20例正常对照均表达SSBP2。与正常对照比较,初发ANLL患者SSBP2mRNA表达水平为(0.410±0.216)与对照组(0.383±0.172)差异无显著性(P>0.05)。结论:初发ANLL中SSBP2mRNA表达无异常改变,SSBP2表达可能并不参与急性非淋巴细胞白血病的发生。 Objective:To explore SSBP2 mRNA level in primary acute myeloid leukemia patients. Methods:Reverse transcription Polymerase chain reaction(RT-PCR) was used to assay the expression level of SSBP2 mRNA in 64 cases of primary acute myeloid leukemia(ANLL)and 20 normal cases ,β-actin was used as contral gene. Results :SSBP2 was normally expressed in 64 cases of primary ANLL and 20 normal cases. The SSBP2 mRNA level in primary ANLL (0. 410±0. 216) was no statistically significant difference compared with in normal cases(0. 383±0. 172)(P〉0.05). Conclusions:Expression of SSBP2 mRNAwas not changed in the primary ANLL patients ,expression of SSBP2 may be not involved in the development of ANLL.
出处 《临床医药实践》 2008年第6期403-404,共2页 Proceeding of Clinical Medicine
关键词 白血病 急性 单链DNA结合蛋白2 逆转录-聚合酶链反应 leukemia acute single-stranded DNA-binding protein 2 RT-PCR
  • 相关文献

参考文献3

  • 1Qian Z,Fenald A A,Godley L A,et al.Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia[J].Proc Natl Acad Sci USA,2002,99(23):14925-14930.
  • 2Liang Hong.SSBP2,a candidate tumor suppressor gene,induce growth arrest and differentiation of myeloid leukemia cells[J].Oncogene,2005,24(16):2625-2634.
  • 3白波,王宏伟.荧光定量PCR检测WT_1基因在白血病中的表达[J].临床医药实践,2004,13(1):8-10. 被引量:1

二级参考文献10

  • 1Call KM,Glaser T,Ito CY et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus [J]. Cell, 1990,60:509-520.
  • 2Pritchard-Jones K,Fleming S, Davidson D et al. The candidate Wilms tumor gene is involved in genitourinary development [J]. Nature, 1990,346 : 194.
  • 3Inoue K,Ogawa H,Sonoda Yet aL. Aberrant over expression of the Wilms tumor gene in human leukemia [J]. Blood, 1997,89 : 1405.
  • 4Mayo MW,Wang CY,Drouin SS et al. WTlmodulates apoptosis by transcriptionally upregulating the bc 1-2 proto-oncogene[J]. EMBO J, 1999,18 : 3990.
  • 5Maheswaran S,Englert C, Bennett Pet al. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis[J]. Gene Devel,1995,9:2143.
  • 6King-Underwood L, Renshow J,Pritchard-Jones K et al. Mutations in the Wilms tumor gene WT1in leukemias [J]. Blood, 1996,87:2171.
  • 7Miwa H, Beran M,Saunders GF et al. Expression of the Wilms tumor gene in human leukemias [J]. Leukemia, 1992,26:405.
  • 8Inoue K,Sugiyama H,Ogawa Het al. WTlas a new prognostic factor and a new marker for the detection of minial residual disease in acute leukemia[J]. Blood, 1994,84:3071.
  • 9Keruzer KA, Saborowski A, Lupberger Jet al. Fluorescent 5-exonclease assay for the absolute quantification of WT1mRNA :implications for monitoring hu-man leukemias[J]. BR J Hematol, 2001,114 : 313.
  • 10Cilloni D, Gottardi E. Quantitative assessment of WT1expression by real time PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients [J]. I.eukemia, 2002,16 : 2115.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部